Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Metzfield DennisVP, PAO & Controller | Tax withholding | F | $20K 229 sh | Feb 4, 2026 |
| 19 | Moore Alexander D.Director | Open-market sale · 10b5-1 plan | SELL | $106K 720 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Jones Jeanne MEVP, CFO, Audit & Risk | Disposition to issuer | D | $314K 7,154 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $187K 4,064 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Morris Philip CDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 19 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $378K 1,639 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 19 | Moore Alexander D.Director | Open-market sale · 10b5-1 plan | SELL | $186K 1,233 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 18 | Howse CurtisSee remarks | Open-market sale · 10b5-1 plan | SELL | $3.80M 52.6K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Gutman CarrieSenior Vice President | Grant or award | A | — 763 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Bendza Gary MarkEVP, CFO | Grant or award | A | — 483.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Malabre Richard CSVP, Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $50K 36.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Hill Donna K.VP, Human Resources | Grant or award | A | — 17.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 24.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Prieskorn Laura LoueneDirector, CEO and President | Grant or award | A | — 146.5K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Raub ChristopherExecutive Vice President | Grant or award | A | — 11.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Cummings Don WEVP and CFO | Grant or award | A | — 14.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Malenka Robert C.Director | Open-market sale | SELL | $18 1 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 17 | Chelko CarrieEVP and General Counsel | Grant or award | A | — 25.9K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Smith NathanChief Financial Officer | Tax withholding | F | $79K 3,859 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $202K 878 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $140K 600 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Frost DianaDirector | Tax withholding | F | $57K 548 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Kleczynski Robert ASVP, Controller & Tax | Disposition to issuer | D | $218K 4,963 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Robinson-Gay DonaldSenior Vice President | Tax withholding | F | $57K 939 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $197K 850 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Clark Kyra ESenior Vice President | Tax withholding | F | $63K 1,045 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $133K 576 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Stetz MattiasChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $353K 20.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Kleczynski Robert ASVP, Controller & Tax | Tax withholding | F | $165K 3,768 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 15 | Frew JamesSEE REMARKS | Option exercise | M | — 50.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Furbee DanielDirector, SEE REMARKS | Option exercise | M | — 51.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | France NatashaSEE REMARKS | Tax withholding | F | $16K 3,100 sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Munari Alvise J.Chief Product Officer | Tax withholding | F | $274K 438 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 15 | Dawsey James MDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | Jahnel DarrinDirector | Grant or award | A | $2,238 69 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | Zalenko Neal F.Director | Small acquisition | L | $6,350 588 sh | Feb 4, 2026 traded Jan 27, 2026 |
| 15 | White Daniel JamesDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 13 | Cota GermaineChief Accting. Off. & VP, Fin. | Grant or award | A | — 3,116 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Biebuyck OlivierPresident, Fab Tech | Option exercise | M | — 1,232 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Lee CindyChief Financial Officer | Tax withholding | F | — 1,108 sh | Feb 4, 2026 traded Feb 2, 2026 |